Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | VYBE | Common Stock, par value $0.001 per share | 72.3M | May 20, 2022 | Direct | F1 | |||||
holding | VYBE | Series A Preferred Stock | 500K | May 20, 2022 | Direct | F2 |
Id | Content |
---|---|
F1 | On May 20, 2022, pursuant to a Share Exchange Agreement dated May 11, 2022 (the "Agreement") by and between Limitless X Holdings Inc. ("Limitless") and Bio Lab Naturals Inc. (the "Issuer"), the reporting person exchanged 37,250,000 shares of Limitless common stock ("Company Shares") for 72,265,000 shares of the common stock of the Issuer (the "Exchange Shares") with the exchange ratio being 1.94 Exchange Shares for each Company Share. |
F2 | On May 20, 2022, pursuant to the Agreement, the reporting person purchased Series A Preferred Stock for a price of $0.80 per share. Each share of Series A Preferred Stock is convertible into two shares of the Issuer's common stock. |